PCSK9 and Sepsis: Nonetheless, genomics of sepsis studies have identified key pathways associated with specific organ dysfunctions and mortality, and have identified drug targets in sepsis (e.g., proprotein convertase subtilisin/kexin type 9 (PCSK9) [5]).